Patients Coming Off Anti-Obesity Medications Put On Pounds at a Quadrupled Rate Than People Using Diet and Exercise

A recent study suggests that patients who come off new slimming jabs like Mounjaro or Wegovy may regain shed pounds far faster than those who end traditional diet and exercise programs.

Findings released in a prominent health publication demonstrates that while obese individuals can lose about a fifth of their total mass while on the medication, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals using such treatments should be aware of the potential of quick rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a reversion to starting mass in about one and a half years.

Comparing Treatments

The research, which looked at 37 of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with other pills.

Scientists point out that people who lose weight through diet and exercise usually see a more gradual creep back—perhaps 100 grams monthly—after stopping.

Explaining the Quick Regain

Doctors believe the mechanism of the jabs explains the accelerated rebound.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making excessive eating much more probable."

A Lifelong Disease?

The NHS recommend the injections for individuals with weight-linked health risks, alongside recommended lifestyle changes.

A number of clinicians contend that, due to the significant potential of relapse, the therapy might need to be ongoing.

This opinion is supported by pharmaceutical companies, who say that the findings "underscore the chronic character of obesity," akin to managing conditions like hypertension.

Patient Experiences

People who have discontinued the jabs explain a intense resurgence of cravings.

"It felt as if something flipping and I was suddenly starving," described an individual.

This challenge is worsened if individuals have not adopted permanent lifestyle or habit changes during therapy.

Significant Use

Recent estimates show that a significant number of adults in the UK have tried these injections in the last 12 months, with interest being substantial.

• Adoption is greater among women compared to males.
• The middle-aged age group shows the greatest usage rates.
• Many obtain the drugs through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while the jabs are powerful agents for weight loss, they are not a magic fix and lasting health benefits likely depends on integrated lifestyle changes.